“We are delighted to welcome Uli to Sever Pharma Solutions. With her strong track record of building high-performing teams and achieving ambitious sales goals in a client-centric CDMO environment, combined with her long experience in the industry, she will be an important part of strengthening our offers and market reach,” says Kenneth Stokholm, CEO.

Ulrike Foley

German-born Ulrike, known as Uli, has over 30 years of experience in business development across various pharmaceutical and CDMO organizations in the U.S. Most recently, she served as VP of Business Development at Adare/Frontida Biopharm, a pharmaceutical development and commercial contract manufacturer based in Philadelphia, U.S, describes the company.

Ulrike Foley will be stationed in Putnam, CT.